Farsin Hamzei | Neuroscience | Best Researcher Award

Prof. Dr. Farsin Hamzei | Neuroscience | Best Researcher Award

Lecture from Moritz Klinik, Germany

Prof. Dr. med. Farsin Hamzei is a highly accomplished neurologist and researcher specializing in neurorehabilitation. With over two decades of experience in academic and clinical neurology, he has significantly contributed to stroke rehabilitation, motor network recovery, and non-invasive brain stimulation techniques. Currently, he serves as the Chief Physician at Moritz Klinik Bad Klosterlausnitz and holds a professorship at Friedrich-Schiller-Universität Jena. His leadership has driven the expansion of rehabilitation services, including the establishment of specialized outpatient centers for neurological recovery. He has received prestigious research grants and awards, highlighting his contributions to innovative therapeutic approaches. His expertise spans functional MRI, transcranial magnetic stimulation (TMS), and diffusion tensor imaging, advancing the understanding of neural plasticity. Prof. Hamzei has also played a vital role in medical education, mentoring students and professionals in neurology and neurorehabilitation. His work is recognized both nationally and internationally, with a focus on improving patient outcomes through cutting-edge research. His leadership in clinical and research settings, along with his dedication to advancing neurorehabilitation, has made him a key figure in the field. His ongoing research aims to refine therapeutic strategies and enhance the effectiveness of rehabilitation for stroke and neurological disorders.

Professional Profile

Education

Prof. Hamzei pursued his medical studies at multiple prestigious German universities. He began his medical education at Johann Wolfgang Goethe University in Frankfurt (1989-1992), where he completed his preliminary medical examination. He continued at Ruprecht-Karls-Universität Heidelberg-Mannheim (1992-1993) and later at Rheinische Friedrich-Wilhelms-Universität Bonn (1993-1995), where he successfully completed his final medical examinations. In 1996, he finished his practical training in oncology, cardiovascular surgery, and neurology at the University Hospital Bonn. He obtained his medical degree and licensure in November 1996. His academic journey also includes a Doctor of Medicine (M.D.) degree awarded in 1997 for his dissertation on cortisol concentration changes in patients with obsessive-compulsive disorder. He later achieved his habilitation in neurology in 2006, focusing on functional studies of motor network organization. Furthering his education in healthcare administration, he obtained a Master of Health Business Administration (MHBA) between 2012 and 2014, equipping him with leadership skills in hospital management and healthcare economics. His comprehensive education in medicine, research, and business administration has enabled him to lead and innovate in neurological rehabilitation, integrating clinical expertise with advanced research methodologies.

Professional Experience

Prof. Hamzei has an extensive career in neurology, research, and medical leadership. He began as a physician in training at the Neurological University Hospital Bonn in 1997. From 1999 to 2000, he received a prestigious research fellowship from the German Research Foundation (DFG) at the Neurological University Hospital Jena. Between 2001 and 2005, he worked as a research associate at the Neurological University Hospital Hamburg-Eppendorf, further developing his expertise in neuroimaging and neurorehabilitation. In 2005, he became a board-certified neurologist and subsequently joined the Neurological University Hospital Freiburg as a senior research associate. By 2007, he was appointed Senior Consultant at the same institution. His academic career flourished when he received the venia legendi for neurology in 2006 and later a professorship in Neurological Rehabilitation at Friedrich-Schiller-Universität Jena in 2009. Since 2010, he has been the Chief Physician of the Neurological Department at Moritz Klinik Bad Klosterlausnitz, where he has led expansions in rehabilitation services. His leadership extends to directing specialized centers, including those for aphasia, dysphagia, and long-COVID therapy. His career reflects a strong balance of clinical practice, research, and medical education.

Research Interests

Prof. Hamzei’s research focuses on neurorehabilitation, motor recovery after stroke, and neural plasticity. He investigates how the brain reorganizes itself following central nervous system damage, using advanced imaging and stimulation techniques. His work explores the adaptation and functional restoration of motor networks post-injury, employing tools like functional MRI, transcranial magnetic stimulation (TMS), and diffusion tensor imaging (DTI). He is particularly interested in training-based changes in the brain, examining how therapies like forced-use therapy, video-assisted rehabilitation, and mirror therapy impact motor recovery. Another key area of his research is non-invasive brain stimulation, including repetitive TMS (rTMS) and transcranial direct current stimulation (tDCS), to enhance neuroplasticity and functional improvement in patients. He also investigates cognitive and motor training for neurorehabilitation, aiming to develop innovative therapies for stroke and neurodegenerative conditions. His research integrates neuroscience, technology, and clinical application, focusing on improving patient outcomes through personalized rehabilitation strategies. Additionally, he collaborates on projects related to aphasia and long-COVID rehabilitation, expanding the scope of his expertise. His contributions have significantly influenced rehabilitation protocols and the understanding of motor network reorganization in patients with neurological disorders.

Research Skills

Prof. Hamzei possesses extensive expertise in neuroimaging and neuromodulation techniques for neurorehabilitation research. He is proficient in functional MRI (fMRI), diffusion tensor imaging (DTI), and voxel-based morphometry, which he uses to analyze brain network reorganization. His skills extend to transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), tools that he employs to investigate and enhance neuroplasticity in patients with motor deficits. He has experience in clinical trial design, having led and contributed to numerous studies evaluating rehabilitation techniques for stroke and neurological disorders. His methodological expertise includes randomized controlled trials (RCTs) and observational studies in neurorehabilitation. Additionally, he is skilled in data analysis and interpretation of neural connectivity changes post-rehabilitation. His research funding achievements demonstrate his ability to secure grants and manage large-scale scientific projects. He also has experience in interdisciplinary collaboration, working with neurologists, physiotherapists, and psychologists to develop innovative rehabilitation approaches. His ability to integrate cutting-edge neuroscience with clinical applications highlights his effectiveness as both a researcher and a clinician. His technical and analytical skills in neurorehabilitation research have contributed to advancements in understanding and treating motor impairments after neurological injury.

Awards and Honors

Prof. Hamzei has received multiple awards in recognition of his contributions to neurorehabilitation research. In 2009, he was awarded the Fritz und Eleonore Hodeige Prize for his development of innovative therapeutic approaches in neurological rehabilitation. This award highlighted his impact on improving rehabilitation techniques for patients recovering from neurological injuries. In 2016, he received third place in the Reha Zukunftspreis from IQMG and BDPK for his work on the “Model-A-Team” in neurological rehabilitation. This recognition was for pioneering a collaborative, interdisciplinary approach to patient recovery. Beyond these prestigious awards, he has consistently received research funding from national and international organizations, including the European Network for Excellence (FP6) and the Bernstein Network for Neurotechnology, which provided over €1 million for his research. His ability to secure major grants further demonstrates his excellence in research and innovation. He has also been appointed to multiple examination committees in Germany, solidifying his influence in shaping future generations of neurologists. These honors reflect his dedication to advancing neurological rehabilitation, integrating research with clinical applications to improve patient care and outcomes.

Conclusion

Prof. Dr. med. Farsin Hamzei is a leading expert in neurorehabilitation, with a distinguished career in academic research, clinical practice, and medical education. His extensive contributions to stroke recovery, motor network adaptation, and non-invasive brain stimulation have significantly advanced the field. Through his leadership at Moritz Klinik and Friedrich-Schiller-Universität Jena, he has expanded rehabilitation services and integrated innovative therapeutic approaches. His research, supported by prestigious grants and awards, focuses on enhancing neuroplasticity and functional recovery through cutting-edge imaging and stimulation techniques. His expertise in neuroimaging, clinical trials, and interdisciplinary collaboration has strengthened rehabilitation strategies for neurological patients. His commitment to education, serving on medical examination boards and mentoring future neurologists, further underscores his influence in the field. Prof. Hamzei’s dedication to improving patient outcomes through research, innovation, and education positions him as a key figure in neurorehabilitation. His continued work will likely shape the future of rehabilitation medicine, advancing both theoretical understanding and practical applications for neurological recovery.

Publications Top Notes

  1. Title: Implicit Motor Learning Under Anodal or Cathodal tDCS During fMRI Induces Partially Distinct Network Responses
    Authors: Farsin Hamzei, Alexander Ritter, Daniel Güllmar
    Year: 2025

  2. Title: A Randomized Controlled Trial to Test the Effects of Repetitive Peripheral Magnetic Stimulation Versus Neuromuscular Electrical Stimulation in Patients with Spastic Hemiparesis After Stroke (REPMAST): Study Protocol
    Authors: Kristin Loreen Pohl, Jens Müller, Katja Wittig-Böttger, Alexander Ritter, Farsin Hamzei
    Year: 2024

  3. Title: Different Effect Sizes of Motor Skill Training Combined with Repetitive Transcranial versus Trans-Spinal Magnetic Stimulation in Healthy Subjects
    Authors: Farsin Hamzei, Alexander Ritter, Kristin Pohl, Peggy Stäps, Eric Wieduwild
    Year: 2024

  4. Title: Understanding the concept of a novel tool requires interaction of the dorsal and ventral streams
    Authors: Gundula Seidel, Michel Rijntjes, Daniel Güllmar, Cornelius Weiller, Farsin Hamzei
    Year: 2023

  5. Title: Accelerated brain ageing in sepsis survivors with cognitive long‐term impairment
    Authors: Gundula Seidel, Christian Gaser, Theresa Götz, Albrecht Günther, Farsin Hamzei
    Year: 2020

  6. Title: Anatomy of brain lesions after stroke predicts effectiveness of mirror therapy
    Authors: Farsin Hamzei, Gabriele Erath, Ursula Kücking, Cornelius Weiller, Michel Rijntjes
    Year: 2020

Jiangang Duan | Neuroscience | Best Researcher Award

Prof. Jiangang Duan | Neuroscience | Best Researcher Award

Chief Physician at Xuanwu Hospital, Capital Medical University, China

Dr. Jiangang Duan is a distinguished neurologist and researcher at the Department of Emergency and Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. With over two decades of clinical and academic experience, he specializes in cerebral venous thrombosis (CVT), ischemic stroke, and neuroprotective therapies. His groundbreaking work includes the development of diagnostic imaging techniques, exploration of biomarkers for venous infarcts, and innovative non-drug therapies for ischemic stroke. Dr. Duan is also a dedicated mentor and educator, shaping the next generation of neurologists through his teaching and supervision of postgraduate students. His extensive research has been published in prestigious journals, and he has contributed to the creation of national guidelines for the management of cerebrovascular diseases.

Professional Profile

Education

Dr. Duan holds a Ph.D. and M.D. in Neurology from West China Hospital, Sichuan University (2004–2007), where his dissertation focused on the neuroprotective effects of acupuncture in ischemic stroke models. He earned an M.S. in Human Anatomy and Histoembryology from West China College of Basic and Forensic Medicine (2001–2004), researching ganglioside GM1’s role in neural stem cell differentiation. His academic journey began with a B.S. in Clinical Medicine from Inner Mongolia Medical College (1991–1996), establishing a strong foundation for his future contributions to neuroscience.

Professional Experience

Dr. Duan is an Associate Professor at the Department of Emergency and Neurology, Capital Medical University, Beijing, since 2015. His clinical and research roles involve pioneering treatment strategies for CVT and ischemic strokes. He previously served as a visiting scholar at the Chinese University of Hong Kong (2012–2013), contributing to long-term studies on cardiovascular risks in diabetic patients. Dr. Duan’s work at Xuanwu Hospital includes innovative projects like using DOACs for CVT treatment, evaluating glucocorticoid efficacy, and exploring NF-κB-NLRP3 inflammasome signaling in thrombosis pathogenesis. His efforts have significantly influenced the field of cerebrovascular disease management in China and beyond.

Research Interests

Dr. Duan’s research primarily focuses on the mechanisms and treatments of cerebrovascular disorders, particularly CVT and ischemic strokes. His interests extend to the role of inflammation in thrombosis, novel non-drug therapies for neuroprotection, and the efficacy of anticoagulants like Dabigatran in CVT management. He also investigates biomarkers, such as serum Claudin-5, for predicting venous infarcts and utilizes advanced imaging techniques like MRBTI to evaluate thrombosis stages. His translational research bridges clinical and preclinical studies, aiming to improve diagnostics, treatments, and outcomes for patients with cerebrovascular diseases.

Research Skills

Dr. Duan is proficient in advanced diagnostic imaging methods, including MRBTI, and skilled in conducting both retrospective and prospective studies. He excels in randomized controlled trials, having evaluated the safety and efficacy of anticoagulants and glucocorticoids in cerebrovascular diseases. His expertise in biomarker identification and inflammasome signaling pathways demonstrates his command of molecular and clinical neurology. Additionally, Dr. Duan is adept at statistical analysis, multidisciplinary collaboration, and guideline development, making him a leading figure in cerebrovascular research and clinical practice.

Honors and Awards

Dr. Duan has received numerous accolades, including the prestigious Chinese Medical Science and Technology Award (2019) for his work on non-drug therapies for ischemic stroke. In 2018, he was awarded a fellowship by the European Stroke Research Foundation, where he presented groundbreaking research at the 27th European Stroke Conference in Athens, Greece. He was also recognized with the Outstanding Mentor Management Award in 2021 for his exemplary guidance of postgraduate students. Earlier honors include a scholarship for master’s students at Sichuan University (2002–2003) and recognition for his contributions to cerebrovascular disease management guidelines in China.

Conclusion

Dr. Jiangang Duan is a strong contender for the Best Researcher Award. His robust track record in neurology research, impactful mentorship, and contributions to clinical practice guidelines highlight his expertise and dedication. While there is room to amplify his global impact through high-impact publications and leadership in international projects, his achievements already position him as a distinguished researcher in his field.

Publication Top Notes

  1. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial
    Authors: Ma, H., Gu, Y., Bian, T., Ji, X., Duan, J.
    Journal: International Journal of Stroke
    Year: 2024
    Volume & Pages: 19(6), pp. 635–644
    Citations: 2
  2. Multicenter registry study of cerebral venous thrombosis in China (RETAIN-CH): Rationale and design
    Authors: Bian, H., Wang, X., Liu, L., Wang, L., Ji, X.
    Journal: Brain and Behavior
    Year: 2024
    Volume & Pages: 14(4), e3353
  3. Night shift work was associated with functional outcomes in acute ischemic stroke patients treated with endovascular thrombectomy
    Authors: Yu, W., Ma, J., Guo, W., Zhao, W., Ji, X.
    Journal: Heliyon
    Year: 2024
    Volume & Pages: 10(4), e25916
  4. Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio
    Authors: Yu, W., Jia, M., Guo, W., Song, H., Ji, X.
    Journal: Current Neurovascular Research
    Year: 2024
    Volume & Pages: 21(1), pp. 6–14
  5. Severe deep cerebral venous thrombosis associated with ulcerative colitis: one case report | 重 症 脑 深 静 脉 血 栓 形 成 并 溃 疡 性 结 肠 炎 一 例
    Authors: Wang, J.-B., Gu, Y.-Q., Duan, J.-G.
    Journal: Chinese Journal of Contemporary Neurology and Neurosurgery
    Year: 2024
    Volume & Pages: 24(3), pp. 193–198
  6. Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis
    Authors: Guo, W., Li, N., Xu, J., Zhao, W., Ji, X.
    Journal: Journal of Clinical Pharmacy and Therapeutics
    Year: 2024
    Volume & Pages: Article ID: 1171260
  7. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
    Authors: Scutelnic, A., van de Munckhof, A., Krzywicka, K., Levi, M., van Gorp, E.C.M.
    Journal: European Stroke Journal
    Year: 2023
    Volume & Pages: 8(4), pp. 1001–1010
    Citations: 1
  8. Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis
    Authors: Liu, L., Zhou, C., Jiang, H., Zhou, C., Ji, X.
    Journal: Thrombosis Journal
    Year: 2023
    Volume & Pages: 21(1), Article 78
    Citations: 1
  9. Impaired Dynamic Cerebral Autoregulation in Patients With Cerebral Venous Sinus Thrombosis: Evaluation Using Transcranial Doppler and Silent Reading Stimulation
    Authors: Chen, S., Chen, H., Duan, J., Liu, R., Xing, Y.
    Journal: Ultrasound in Medicine and Biology
    Year: 2023
    Volume & Pages: 49(10), pp. 2221–2226
  10. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
    Authors: van de Munckhof, A., Borhani-Haghighi, A., Aaron, S., Ferro, J.M., Coutinho, J.M.
    Journal: International Journal of Stroke
    Year: 2023
    Volume & Pages: 18(9), pp. 1112–1120
    Citations: 3

 

Zhongqing Sun | Neuroscience | Best Researcher Award

Dr. Zhongqing Sun | Neuroscience | Best Researcher Award

Assistant Researcher at Xijing Hospital, China

Dr. Zhongqing Sun is an accomplished assistant researcher specializing in neurobiology, with a strong focus on neural regeneration and neuroprotection. His academic journey has led him through prestigious institutions such as The University of Hong Kong and Jinan University, contributing significantly to research on neurological diseases like Alzheimer’s, epilepsy, and stroke. As a leader in translational neuroscience, he integrates basic research with clinical applications, employing innovative techniques to explore potential therapies. Dr. Sun’s work combines cutting-edge molecular biology tools, including RNA-seq, live cell imaging, and stem cell therapies, to investigate new treatments for neurodegenerative diseases. His contributions extend through various high-impact publications and collaborative projects. He continues to drive forward research initiatives with the goal of improving the quality of life for patients with neurological conditions.

Professional Profile

Education:

Dr. Zhongqing Sun holds a Ph.D. in Orthopaedics and Traumatology from The University of Hong Kong, where his research focused on neural regeneration and repair. He completed his Master’s degree in Pharmacology at Jinan University, specializing in the regenerative aspects of the central nervous system, and his Bachelor’s degree in Preventive Medicine from Henan University of Chinese Medicine. This extensive educational background laid a solid foundation for his research in the field of neurology and regenerative medicine, particularly in the context of neurological diseases.

Professional Experience:

Dr. Sun’s professional experience spans multiple prestigious institutions. He is currently an Assistant Researcher at Xijing Hospital, The Fourth Military Medical University, where he leads translational research on common neurological diseases, such as Alzheimer’s disease and stroke. Prior to this, he worked as a research assistant at The University of Hong Kong, focusing on neurodegenerative diseases and eye health, specifically Alzheimer’s and glaucoma. Additionally, he gained valuable experience at The Chinese University of Hong Kong, where he investigated pain mechanisms and the role of microglia in neuropathic pain. He has also contributed to research in electrophysiological recording at the Shanghai Institute of Neuroscience.

Research Interests:

Dr. Sun’s primary research interests lie in the neural regeneration and neuroprotection of the central nervous system. His focus includes developing therapeutic strategies for common neurological conditions, such as Alzheimer’s disease, stroke, and epilepsy. He explores a variety of methodologies, including stem cell therapy, electrical stimulation, neuroinflammatory modulation, and the use of traditional Chinese medicine like Goji berries. His work aims to bridge basic neuroscience with clinical applications, particularly in the development of new treatments for neurodegenerative diseases.

Research Skills:

Dr. Sun is proficient in a wide range of advanced research techniques used to study the central nervous system and neurological diseases. His skills include primary cell culture, cell line maintenance, transgenic animal models, behavioral analysis, electrophysiology, immunostaining, and live cell imaging. He is also experienced in high-throughput molecular techniques such as RNA-seq, single-cell sequencing, Western blotting, and PCR. These technical competencies enable him to conduct in-depth studies on neuroprotection and regeneration, laying the groundwork for novel therapeutic approaches to neurological disorders.

Awards and Honors:

Dr. Zhongqing Sun has been recognized for his outstanding contributions to the field of neuroscience. His work on neural regeneration has earned him numerous accolades, including research grants and awards for innovation. He has received funding from prestigious institutions, such as The University of Hong Kong, and has contributed to several high-profile research projects in the field. His publications in top-tier journals like Biomaterials and Neural Regen Res further attest to his scientific leadership and the impact of his research. Additionally, he serves as a peer reviewer for journals, further validating his expertise and recognition within the scientific community.

Conclusion:

Zhongqing Sun has demonstrated exceptional promise and significant contributions to neuroscience, particularly in neurodegenerative diseases. His interdisciplinary approach to neural regeneration and neuroprotection, combined with his leadership in high-impact research projects, positions him as a strong contender for the Best Researcher Award. To strengthen his profile, expanding the clinical and public outreach of his research could further cement his influence in the field. Given his combination of innovative research, leadership, and academic rigor, he is a deserving candidate for the award.

Publication Top Notes:

  1. Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
    • Authors: Sun, Z., Zhang, X., So, K.-F., Jiang, W., Chiu, K.
    • Year: 2024
    • JournalBiomolecules
    • Volume: 14
    • Issue: 7
    • Article Number: 833
    • Citations: 0
  2. Retinal safety and toxicity study of artesunate in vitro and in vivo
    • Authors: Lu, B.-W., Liang, Y.-X., Liu, J.-F., So, K.-F., Chiu, K.
    • Year: 2023
    • JournalAdvances in Ophthalmology Practice and Research
    • Volume: 3
    • Issue: 2
    • Pages: 47–54
    • Citations: 0
  3. Effects of Goji with different origins or different extraction methods on primary mixed glial cells (不同产地或提取工艺枸杞对原代胶质细胞抗氧化及抗炎作用的影响)
    • Authors: Zheng, C., Zhu, R., Sun, Z., So, K.-F., Chiu, K.
    • Year: 2022
    • JournalKexue Tongbao/Chinese Science Bulletin
    • Volume: 67
    • Issue: 4-5
    • Pages: 376–384
    • Citations: 2
  4. Lycium barbarum extract promotes M2 polarization and reduces oligomeric amyloid-β-induced inflammatory reactions in microglial cells
    • Authors: Sun, Z.-Q., Liu, J.-F., Luo, W., Hu, Y., Chiu, K.
    • Year: 2022
    • JournalNeural Regeneration Research
    • Volume: 17
    • Issue: 1
    • Pages: 203–209
    • Citations: 14
  5. Electrical stimulation at nanoscale topography boosts neural stem cell neurogenesis through the enhancement of autophagy signaling
    • Authors: He, L., Sun, Z., Li, J., Zhou, Q., Chiu, K.
    • Year: 2021
    • JournalBiomaterials
    • Volume: 268
    • Article Number: 120585
    • Citations: 45
  6. Electrical stimulation affects neural stem cell fate and function in vitro
    • Authors: Zhu, R., Sun, Z., Li, C., Chiu, K., He, L.
    • Year: 2019
    • JournalExperimental Neurology
    • Volume: 319
    • Article Number: 112963
    • Citations: 135